Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cathepsin L pseudogene 6 (CTSLP6) is a non-protein-coding pseudogene related to the cathepsin L gene family. Unlike the functional cathepsin L enzyme, which is a lysosomal cysteine protease involved in protein catabolism and viral entry, CTSLP6 does not encode a functional enzyme or protein product. Pseudogenes like CTSLP6 are typically genomic sequences that resemble protein-coding genes but have lost their protein-coding potential due to mutations, deletions, or the absence of necessary regulatory elements. While some pseudogenes regulate parent gene expression via noncoding RNA products or RNA interference in other contexts, there is no evidence that CTSLP6 has such a function. It is not considered a therapeutic target or clinically relevant biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cathepsin L pseudogene 6 (CTSLP6).